5th Annual Cell & Gene Therapy Congress

Date: 24-Oct-19 to 25-Oct-19
Location: Hotel Novotel London West / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

We will welcome over 350 delegates representing leading biotechnology companies, global pharmaceutical organisations, and internationally renowned academic institutions.

Over 30 presentations, case studies and panel discussions focussed on Cell & Gene Therapy development and clinical research, the commercialisation of CAR T treatments, and Cell & Gene Therapy bioprocessing and manufacturing strategies.

3 interactive streams:

Day 1 Stream 1: Cell & Gene Therapy Development & Clinical Trials
Day 1 Stream 2: Cell & Gene Therapy Bioprocessing & Manufacturing Strategies
Day 2 Stream 1: Commercialising Cell & Gene Therapy Treatments
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

Co-located with our highly anticipated 8th Annual Cell Culture & Bioprocessing Congress, 6th Annual Stem Cell & Regenerative Medicine Congress and 2nd Annual Biobanking Congress.

Exhibitors

Axel Hoos, Senior Vice President & Oncology Therapeutic Area Head, GlaxoSmithKline, Peter Olagunju, Vice President, Patient Operations & Lentiglobin Program Leader, bluebird bio, David Gilham, Vice President, Research & Development, Celyad, Paul Lammers, President & Chief Executive Officer, Triumvira Therapeutics, Soraya Bekkali, Chief Executive Officer, Gyroscope Therapeutics

Go to event website